Wuxi Biologics (Cayman), Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Wuxi Biologics (Cayman), Inc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 6.01% vs 43.17% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -25.43% vs 25.12% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18,822.80",
          "val2": "17,755.60",
          "chgp": "6.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,876.80",
          "val2": "6,271.60",
          "chgp": "-6.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "175.10",
          "val2": "74.90",
          "chgp": "133.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-30.10",
          "val2": "410.40",
          "chgp": "-107.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,945.50",
          "val2": "5,291.00",
          "chgp": "-25.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "230.90%",
          "val2": "284.90%",
          "chgp": "-5.40%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

18,822.80

17,755.60

6.01%

Operating Profit (PBDIT) excl Other Income

5,876.80

6,271.60

-6.30%

Interest

175.10

74.90

133.78%

Exceptional Items

-30.10

410.40

-107.33%

Consolidate Net Profit

3,945.50

5,291.00

-25.43%

Operating Profit Margin (Excl OI)

230.90%

284.90%

-5.40%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is 6.01% vs 43.17% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -25.43% vs 25.12% in Dec 2022

All Annual Results